TABLE 1

Type 2 diabetes–associated SNPs for the type 1 diabetes analysis

LocusChr.Reported type 2 diabetes association (ref)HumanHap500 markerHapMap CEU r2Genotyping success (%)MendErrHW P
PPARG3p25rs1801282 (15)rs21974231.00099.900.803
IGF2BP23q27.2rs4402960 (10,11,13)rs440296098.700.932
rs1470579 (13)0.978
WFS14p16rs10010131 (16)rs100129461.00099.600.045
CDKAL16p22.3rs10946398 (10)rs47125231.00099.900.275
rs7754840 (10,11,13)
CDKAL16p22.3rs7756992 (12)rs775699299.900.270
SLC30A88q24.11rs13266634 (9–13)rs1326663499.600.291
CDKN2A/B9p21rs564398 (10)rs14128290.96599.900.533
CDKN2A/B9p21rs10811661 (10,11,13)rs23832081.00099.900.875
IDE/HHEX10q23.33rs1111875 (9–11,13)rs1111875100.000.552
rs5015480 (10)0.958
IDE/HHEX10q23.33rs7923837 (9)rs7923837100.000.856
KCNJ1111p15rs5215 (8,10)rs521599.700.067
FTO16q12.2rs8050136 (10,11)rs805013699.900.664
HNF1B17cen-q21.3rs7501939 (17)rs750193999.700.599
rs757210 (18)0.811
  • HW, Hardy-Weinberg equilibrium test of the control group in the case-control cohort.